Diagnostics & Tools May 2022

Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.

• Ultima Genomics has received $600mm in a round of funding
• GTCR has acquired PathGroup
• QIAGEN has agreed to acquire BLIRT